Loading…
← CockpitCompetitor Analysis › SHL.DE Siemens Healthineers AGOpen in the cockpit ↗

Siemens Healthineers AGSHL.DECompetitor analysis, valuation and peers

Germany · EUR·Health Care›Medical Specialties

Spun off from Siemens: makes medical imaging equipment (MRI, CT, X-ray), lab diagnostics and cancer therapy systems for hospitals.

≈ Germany's GE HealthcareMomentum leader 89
Mkt cap
$53.7B
US dollars, full cap
Free float
32%
of shares outstanding
$/day
$51.9M
20-day average traded
Fwd P/E
18.9×
forward earnings
ROIC−WACC
+0.2 pp
WACC 7.1%
Hurdle
+4 pp
Req g minus delivered
Next earnings
78 days
4 Feb 2027
Close · EUR€43.84
1D+1.2%
1W+0.7%
1M+5.8%
3M+9.1%
6M+26.6%
YTD-2.4%
1Y+6.0%
ATR %2.2%
52w lowhigh7.2% off high

What Siemens Healthineers does

Spun off from Siemens: makes medical imaging equipment (MRI, CT, X-ray), lab diagnostics and cancer therapy systems for hospitals.

Sells imaging and lab systems to hospitals in large one-off purchases, then earns again from service contracts and reagents, the chemicals used in lab tests, across the installed base. Siemens kept the majority at the 2018 listing. The 2021 purchase of Varian added radiotherapy, a market where cancer-treatment machines pair with its imaging.

In one line: Germany's GE Healthcare.

Products and services

  • Imaging (MRI, CT, X-ray, ultrasound)
  • Diagnostics (lab testing)
  • Varian (radiation oncology systems)
  • Advanced therapies (image-guided surgery)

Customers

  • Hospitals & imaging centers
  • Diagnostic labs
  • Oncology treatment centers

Where it sits in the supply chain

  • Medical devices
  • Diagnostic imaging & lab equipment…
  • Imaging (MRI/CT), diagnostics, Varian…

What could go right

  • Aging population/imaging volume growth
  • Oncology equipment demand
  • Service/consumables recurring revenue

What could go wrong

  • Hospital capex cycles
  • Reimbursement pressure on imaging
  • Competition from lower-cost imaging makers

Moat: wide (installed base, switching costs, customer qualification). Large installed base of imaging equipment generates long-term service/consumables revenue and high switching costs.

Headquarters: Erlangen, Germany · Founded: 2018 · Employees: 74,600

Named competitors

Siemens Healthineers at a glance

Size Siemens Healthineers (SHL.DE) is a Germany Health Care company (Medical Specialties) with a market value of $53.7B, the 14th largest of 198 Germany companies the cockpit tracks. Shares closed at €43.84 on 18 Nov 2026.

Performance Over six months the shares gained 26.6%, against +26.5% for the median peer and -0.9% for the Germany market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue grew 1.1% over the last twelve months (peer median +8.7%); the operating margin is 14.2% (peer median 21.1%).

Valuation It trades at 18.9× forward earnings against a peer median of 27.5× (4th cheapest of 21).

Price implies For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 0.2 points above its cost of capital (7.1% WACC).

Next results Next results expected around 4 Feb 2027 (exchange calendar; dates can move).

Relative performance

10011012013021 May 202621 Aug 202618 Nov 2026SHL.DE 125Peer median 122
Six months, rebased to 100: Siemens Healthineers against the median of its 20 peers (local-currency closes).

Siemens Healthineers financials

Reported figures in EUR; fiscal year ends 2026-09-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue€23.6B€23.6B€23.4B€22.4B€21.7B
Revenue growth—+1%+5%+3%—
Gross profit€9.11B€9.11B€9.03B€8.47B€7.71B
EBITDA€4.54B€4.36B€4.73B€4.52B€4.00B
Net income€2.21B€2.21B€2.14B€1.94B€1.51B
Free cash flow€2.03B€2.03B€2.27B€1.77B€971M
Capital expenditure€842M€842M€818M€696M€838M
Total debt€14.7B€14.7B€15.1B€16.2B€16.7B

Quarterly statements and history in the cockpit →

Siemens Healthineers competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%+60%-10%0%+10%+20%IDXXMDLNA7741BDXEWWATBSXGEHCALCMTDRMD300760ILMNELDXCMWSTSTE4543SHL.DE6-month return →1-month return →
Up and to the right = strong over both horizons. Siemens Healthineers is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%20×30×40×IDXXMDLNA7741BDXEWWATBSXGEHCALCMTDRMD300760ILMNELWSTSTEDIM4543SHL.DERevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Siemens Healthineers is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%+30%0%10%20%30%IDXXMDLNA7741BDXEWWATBSXGEHCALCMTDRMD300760ILMNELDXCMWSTSTEDIM4543SHL.DEGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Siemens Healthineers is the large dot.

Siemens Healthineers competitors and peer comparison

Head to head with its named competitors (SHL.DE vs GEHC vs PHIA.AS vs 7751.T)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Siemens Healthineers SHL.DE$53.7B+27%+1%14%18.9×9.6%
GE HealthCare GEHC$37.8B+30%+7%14%15.6×5.0%
Koninklijke Philips PHIA.AS$29.0B+17%-1%10%16.4×5.9%
Canon 7751.T$29.2B+15%+4%10%12.7×0.5%
Elekta EKTA-B.ST$2.35B0%-7%6%15.3×10.7%

How Siemens Healthineers compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Siemens Healthineers against its 20 peers (data as of 18 Nov 2026)
MeasureSHL.DEPeer medianRank in peer set
1-month return+5.8%+7.3%10th lowest of 21
6-month return+26.6%+26.5%11th highest of 21
Distance from 52-week high-7.2%-8.3%10th highest of 21
Revenue growth (TTM)+1.1%+8.7%3rd lowest of 21
Operating margin14.2%21.1%6th lowest of 21
Forward P/E18.9×27.5×4th cheapest of 21
Growth the price implies (Req g, 7 yrs)9.6%16.5%7th least demanding of 21
Growth delivered (Del g)+5.6%+9.4%5th lowest of 21
Hurdle (Req g minus delivered)+4.0 pp+4.9 pp11th least demanding of 21
ROIC minus cost of capital+0.2 pp+3.9 pp6th lowest of 21
EV / EBITDA13.5×20.2×5th cheapest of 20
Net debt / EBITDA2.7×1.1×3rd most indebted of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Siemens Healthineers SHL.DEGermany$53.7B+27%+1%14%18.9×9.6%+5.6%
Idexx Laboratories IDXXUnited States$55.0B+26%+12%32%42.9×29.0%+9.7%
Medline MDLNUnited States$51.5B+8%+12%6%25.6×15.9%+9.9%
Agilent Technologies AUnited States$50.0B+56%+9%24%27.0×23.3%+5.4%
Hoya 7741.TJapan$49.0B-16%+13%32%27.7×14.1%+11.6%
Becton Dickinson BDXUnited States$58.9B+48%-7%16%16.3×-1.6%+0.3%
Edwards Lifesciences EWUnited States$60.5B+27%+13%29%32.3×17.1%+6.7%
Waters WATUnited States$45.8B+37%+81%10%29.1×48.1%+6.0%
Boston Scientific BSXUnited States$63.3B-23%+9%21%14.1×5.8%+15.2%
GE HealthCare GEHCUnited States$37.8B+30%+7%14%15.6×5.0%+3.7%
Alcon ALC.SWSwitzerland$36.9B+18%+1%12%21.5×12.2%+6.1%
Mettler Toledo MTDUnited States$34.6B+60%+7%29%33.7×20.1%+5.5%
ResMed RMDUnited States$34.1B+16%+9%34%19.7×5.7%+12.1%
Shenzhen Mindray Bio-Medical Electronics 300760.SZChina$33.6B+15%+5%28%27.3×1.0%+9.7%
Illumina ILMNUnited States$31.8B+48%+6%21%35.2×27.2%+6.0%
EssilorLuxottica EL.PAFrance$91.9B+5%+8%12%24.8×18.4%+14.6%
Dexcom DXCMUnited States$30.8B+16%+13%24%28.0×19.6%+19.3%
West Pharmaceutical Services WSTUnited States$28.1B+32%+13%23%40.2×25.8%+7.4%
Steris STEUnited States$25.2B+21%+8%20%21.9×14.0%+13.8%
Sartorius Stedim Biotech DIM.PAFrance$24.2B+32%+4%19%45.7×33.4%+9.2%
Terumo 4543.TJapan$24.0B+32%+15%17%27.8×8.8%+13.0%

Questions

Who are Siemens Healthineers's main competitors?
Named competitors: GE HealthCare Technologies (GEHC), Royal Philips (PHIA.AS), Canon Medical (Canon) (7751.T), Elekta AB (EKTA-B.ST). The cockpit's measured peer set (industry) also includes Idexx Laboratories (IDXX), Medline (MDLN), Agilent Technologies (A), Hoya (7741.T), Becton Dickinson (BDX), Edwards Lifesciences (EW).
Is Siemens Healthineers expensive compared with its peers?
On forward p/e it trades at 18.9× against a peer median of 27.5×, 4th cheapest of 21 in its peer set. For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Siemens Healthineers stock performed?
Over six months to 18 Nov 2026 the shares returned +26.6% against +26.5% for the median peer; over one year +6.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.